Eli Lilly and Company (LLY)

Index:

S&P 100

$ 0.00
   
  • Closing Price Chg:
    $37.23
  • 52 Week High: $1,109.94
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 0
  • RiskGrade: 179
  • Beta: 0.02

Latest ShareCast News

Abivax shares soar on rumoured €15bn bid from Eli Lilly

By Benjamin Chiou

Date: Monday 12 Jan 2026

(Sharecast News) - Shares in Nasdaq-listed Abivax soared in pre-market trading on Monday after reports emerged that pharma giant Eli Lilly was preparing a $17.5bn bid for the Paris-based biotech firm.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 1,078.52
Closing Price Change $ 37.23
% Change 0.00 %
52 Week High $1,109.94
52 Week Low $625.65
Volume 0
Shares Issued 948.17m
Beta 0.02
RiskGrade 179

What The Brokers Say

Strong Buy 12
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page